Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • Pimobendan - Heart Failure
    Clinical Study Number 116.36
    Study Indication Heart Failure
    Product Pimobendan
    Generic Name Pimobendan
    Lab Code
    Clinical Phase III
    Study Title

    UDCG 115 in the treatment of patients with terminal heart failure (NYHA IV) despite optimal conventional treatment (compassionate use)

    Study Document
    Trial synopsis 116.36 english